Please assess the completion status of the following clinical trial:

Trial Title: Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* triglycerides 150-500 mg/dL~* age 21-65 years~* generally healthy~* body mass index (BMI) 20-39 kg/m2~Exclusion Criteria:~* smoking~* premenopausal (if female)~* use of hormone replacement or oral contraceptives~* use of lipid lowering or blood pressure medication~* hypertension (blood pressure \> 150/95 mm Hg)~* peripheral vascular disease~* heart disease, diabetes, or stroke~* inflammatory disease (e.g. rheumatoid arthritis or Crohn's)~* elevated liver enzymes~* high intake of omega-3 containing foods~* allergy to adhesive or latex~* use of aspirin, anticoagulants, or SSRI

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 4g P-OM3, then 1g P-OM3, then Placebo (Type: EXPERIMENTAL): 4 g/day Dose Prescription Omega-3 acid ethyl esters (P-OM3)capsules(4) for first intervention (8 weeks), followed by 1g/day P-OM3 capsules(4) for 2nd intervention (8 weeks), followed by Placebo corn oil capsules, 4/day, for the 3rd intervention (8 weeks).
- 1g P-OM3, then 4g P-OM3, then Placebo (Type: EXPERIMENTAL): 1g capsules for 8-wks, followed by 6-wk washout. 4g capsules for 8 wks,followed by 6-wk washout. Placebo capsules for 8-wks.
- Placebo, then 4g P-OM3, then 1g P-OM3 (Type: EXPERIMENTAL): Corn Oil placebo capsules for 8-wks, followed by 6-wk washout. 4g P-OM3 capsules for 8-wks, followed by 6-wk washout. 1g P-OM3 for 8-wks.
- 4g P-OM3, then Placebo, then 1g P-OM3 (Type: EXPERIMENTAL): 4g capsules for 8-wks, followed by 6-wk washout. Placebo capsules for 8-wks, followed by 6-wk washout. 1g capsules for 8 wks.
- 1g P-OM3, then Placebo, then 4g P-OM3 (Type: EXPERIMENTAL): 1g capsules for 8-wks, followed by 6-wk washout. Placebo capsules for 8-wks, followed by 6-wk washout. 4g capsules for 8 wks.
- Placebo, then 1g P-OM3, then 4g P-OM3 (Type: EXPERIMENTAL): Corn oil placebo capsules for 8-wks, followed by 6-wk washout.1g capsules for 8-wks, followed by 6-wk washout. 4g capsules for 8 wks.

Based on this trial design, predict the completion outcome and termination type (if applicable).